{
  "nctId": "NCT03231358",
  "briefTitle": "Our Family Our Future: A Resilience-oriented Family Intervention to Prevent Adolescent HIV/STI Infection and Depression in South Africa",
  "officialTitle": "Our Family Our Future: A Resilience-oriented Family Intervention to Prevent Adolescent HIV/STI Infection and Depression in South Africa",
  "protocolDocument": {
    "nctId": "NCT03231358",
    "filename": "Prot_SAP_000.pdf",
    "label": "Study Protocol and Statistical Analysis Plan",
    "date": "2021-11-17",
    "uploadDate": "2024-12-17T09:43",
    "size": 645413,
    "downloadUrl": "https://clinicaltrials.gov/api/v2/studies/NCT03231358/document/Prot_SAP_000.pdf",
    "hasProtocol": true,
    "hasSap": true,
    "hasIcf": false
  },
  "phase": [
    "PHASE3"
  ],
  "studyType": "INTERVENTIONAL",
  "allocation": "RANDOMIZED",
  "interventionModel": "PARALLEL",
  "masking": "SINGLE",
  "enrollmentInfo": {
    "enrollmentCount": 1758,
    "enrollmentType": "ACTUAL"
  },
  "timeline": {
    "startDate": "2018-11-21",
    "completionDate": "2024-07-31",
    "primaryCompletionDate": "2022-08-31",
    "firstSubmitDate": "2017-07-21",
    "firstPostDate": "2017-07-27"
  },
  "eligibilityCriteria": {
    "criteria": "Inclusion Criteria:\n\n* 14-16 years\n* adolescent concurs that the adult identified is their parent (to also include primary caregivers in the pa-rental role)\n* when more than one child in the family falls within the eligible age range, one child will be chosen at random\n* lives in the household at least 4 days a week\n\nExclusion Criteria:\n\n* no or low symptoms (\\<6) or clinically significant thresholds of depression (16+)",
    "healthyVolunteers": true,
    "sex": "ALL",
    "minimumAge": "14 Years",
    "maximumAge": "16 Years",
    "stdAges": [
      "CHILD"
    ]
  },
  "endpoints": {
    "primary": [
      {
        "measure": "Prevalence of HIV and/or Chlamydia and/or Gonorrhoeae",
        "description": "We will examine whether the intervention produces reductions in HIV and STI prevalence using biological tests for HIV, Chlamydia trachomatis, and Neisseria gonorrhoeae. We report on the prevalence of any HIV or STI (positive for one or more of HIV and/or Chlamydia and/or Neisseria).",
        "timeFrame": "12 months"
      },
      {
        "measure": "Number of Participants Engaged In Vaginal Sex",
        "description": "We will examine whether the intervention produces reductions in the number of participants engaged in vaginal sex and condom use.",
        "timeFrame": "12 months"
      },
      {
        "measure": "Depressive Symptoms",
        "description": "We will examine whether the intervention produces reductions in depressive symptoms. Depressive symptoms will be measured through symptom scores on the Center for Epidemiologic Studies Depression Scale. Scores are summed, and range from 0 to 60. Higher scores correspond with worse depressive symptoms. There are ranges for the severity of depressive symptoms and these are as follows:\n\n0-15: May indicate no or low levels of depressive symptoms. 16 or higher: Suggests a risk for clinically significant depressive symptoms.",
        "timeFrame": "12 months"
      }
    ],
    "secondary": [],
    "other": []
  },
  "complexityMetrics": {
    "eligibilityCriteria": {
      "inclusionCount": 1,
      "exclusionCount": 1,
      "totalCount": 2
    },
    "endpoints": {
      "primaryCount": 3,
      "secondaryCount": 0,
      "otherCount": 0,
      "totalCount": 3
    },
    "studyDesign": {
      "phases": [
        "PHASE3"
      ],
      "isRandomized": true,
      "isMasked": true,
      "interventionModel": "PARALLEL"
    },
    "overallComplexityScore": 59,
    "complexityCategory": "Complex"
  },
  "collectionDate": "2025-09-22T02:30:21.824Z",
  "dataSource": "ClinicalTrials.gov API v2 - Comprehensive Collection"
}